|Articles|April 1, 2020
- BioPharm International-04-01-2020
- Volume 33
- Issue 4
BioPharm International, April 2020 Issue (PDF)
Click the title above to open the BioPharm International April 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Bioreactors Redefine Upstream Productivityalmost 6 years ago
Critical Knowledge for Preparing Auditsalmost 6 years ago
Can Vaccine Development Be Safely Accelerated?almost 6 years ago
Lower Taxes, More Flexibility Crucial to Retaining Pharma Employmentalmost 6 years ago
What’s New in Downstream Technologiesalmost 6 years ago
Benchtop Centrifugesalmost 6 years ago
Chromatography Columnsalmost 6 years ago
Ensuring Smooth Tech Transfer of Bioprocess Operationsalmost 6 years ago
Biosimilars Tackle Interchangeability Standardsalmost 6 years ago
Contamination Control for Cell TherapyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
